|
Volume 271, Number 46,
Issue of November 15, 1996
pp. 29060-29066
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Immobilization of the C-terminal Extension of Bovine
A-Crystallin Reduces Chaperone-like Activity*
(Received for publication, June 13, 1996, and in revised form, September 4, 1996)
Ronald H. P. H.
Smulders
,
John A.
Carver
§,
Robyn A.
Lindner
§,
Martinus A. M.
van Boekel
,
Hans
Bloemendal
and
Wilfried W.
de
Jong
¶
From the Department of Biochemistry, University of
Nijmegen, 6500 HB Nijmegen, The Netherlands and the
§ Department of Chemistry, University of Wollongong,
Northfields Avenue, Wollongong, New South Wales 2522, Australia
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
Acknowledgments
REFERENCES
ABSTRACT
-Crystallins occur as multimeric complexes,
which are able to suppress precipitation of unfolding proteins.
Although the mechanism of this chaperone-like activity is unknown, the
affinity of -crystallin for aggregation-prone proteins is probably
based on hydrophobic interactions. -Crystallins expose a
considerable hydrophobic surface to solution, but nevertheless they are
very stable and highly soluble. An explanation for this paradox may be
that -crystallin subunits have a polar and unstructured C-terminal extension that functions as a sort of solubilizer. In this paper we
have described five A-crystallins in which charged and hydrophobic residues were inserted in the C-terminal extension. Introduction of
lysine, arginine, and aspartate does not substantially influence chaperone-like activity. In contrast, introduction of a hydrophobic tryptophan greatly diminishes functional activity. CD experiments indicate that this mutant has a normal secondary structure and fluorescence measurements show that the inserted tryptophan is located
in a polar environment. However, NMR spectroscopy clearly demonstrates
that the presence of the tryptophan residue dramatically reduces the
flexibility of the C-terminal extension. Furthermore, the introduction
of this tryptophan results in a considerably decreased thermostability
of the protein. We conclude that changing the polarity of the
C-terminal extension of A-crystallin by insertion of a highly
hydrophobic residue can seriously disturb structural and functional
integrity.
INTRODUCTION
The composition of the vertebrate eye lens is dominated by a group
of structural proteins known as crystallins. The largest of these,
-crystallin, is a dynamic multimeric complex composed of two types
of homologous subunits, A- and B-crystallin (1). A few years ago,
it was discovered that these subunits are also constitutively expressed
in various non-lenticular tissues, suggesting that their function is
more than merely structural (2, 3, 4, 5). In addition, increased expression
of B-crystallin has been observed in a variety of neurodegenerative
disorders such as multiple sclerosis (6), Alexander's disease (7, 8),
and Alzheimer's disease (9, 10). Although the physiological significance of this extralenticular expression is unknown, it certainly relates to the fact that -crystallins belong to the family
of small heat shock proteins (hsp)1 (11,
12). Among the shared features of -crystallins and other small hsp
are the conferring of thermotolerance (13, 14), interaction with actin
(15, 16), phosphorylation (17, 18), and intracellular relocalization
upon stress (19, 20). Furthermore, in vitro experiments have
shown that A- and B-crystallin as well as hsp25 can act as
molecular chaperones by suppressing aggregation of denaturing proteins
(21, 22, 23). Unfortunately, the mechanism of this functional activity is
unclear because the three-dimensional structure of -crystallin is
unknown.
Native -crystallins occur as polydisperse particles with an average
molecular mass of about 800 kDa. Understanding the multimeric arrangement of these subunits is essential for defining
structure-function relationships. Recently, solvent-accessible
cylindrical (24) and open micellar arrangements (25) were proposed as
alternatives for previous models such as the solid three-layered (26,
27) and rhombododecahedric structures (28). However, none of these quaternary structure models is based on substantial experimental evidence. The subunits mainly comprise -sheets (29, 30), and several
biophysical studies endorse a tertiary structure composed of two
compact domains and an unstructured C-terminal region (31, 32, 33, 34). Indeed,
as shown by NMR spectroscopy, -crystallin (35) and hsp25 (36) have
unstructured, flexible, and solvent-exposed C-terminal extensions.
Finally, like other chaperones, such as GroEL, -crystallin seems to
suppress aggregation by providing appropriately placed hydrophobic
surfaces for denaturing protein substrates (37, 38, 39).
The purpose of the present work is to study the influence of the
C-terminal extension on chaperone-like activity. It is known that the
extensions are very sensitive to various kinds of enzymatic and
non-enzymatic modifications (for a review see Ref. 1). For example,
enzymatic truncation of the C terminus with calpain II or trypsin
results in a decreased chaperone-like activity (40, 41). Although
sequence alignment shows that the extensions in -crystallins and
small hsp are quite variable, their composition is remarkably dominated
by polar and charged amino acid residues (12, 42). This suggests that
the extensions may have a role in solubilizing the hydrophobic
complexes formed between -crystallin particles and denatured
proteins. To explore such a hypothesis, we have studied the structure
and functional behavior of a number of A-crystallin mutants in which
charged and hydrophobic residues were inserted into the C-terminal
extension.
EXPERIMENTAL PROCEDURES
Materials
Ampicillin, chloramphenicol,
isopropyl-1-thio- -D-galactopyranoside, bovine pancreas
insulin, dithiothreitol, and protease inhibitors were obtained from
Sigma. 8-Anilino-1-naphthalenesulfonic acid was
purchased from Molecular Probes. The Escherichia coli strain
used for expression experiments was B BL21(DE3)pLysS (43).
Expression and Purification
cDNAs encoding wild-type
and mutants of bovine A-crystallin were transformed in the host
E. coli B BL21(DE3)pLysS. Induction, cell lysis, and
fractionation were essentially performed as described by Merck et
al. (33). Proteins were purified via anion exchange chromatography
with a Fast Flow DEAE-Sepharose column (Pharmacia Biotech Inc.) and a
DE52 column (Whatman) (44). For structural and functional studies,
wild-type and mutants were refolded in urea as described previously
(44).
Chaperone Assay
Chaperone-like activity was determined
essentially as described by Farahbakhsh et al. (45).
Briefly, various amounts of wild-type and mutant A-crystallins (61, 122, or 245 µg) were preincubated with 245 µg of bovine pancreas
insulin for 3 min at 40 °C. Denaturation of insulin was initiated by
addition of 20 µl of 1 M dithiothreitol and scattering
was monitored for 15 min at 360 nm using a Perkin-Elmer Lambda 2 UV-visible spectrophotometer equipped with a thermostated circulating
water bath and a thermocouple to register the sample temperature. Total
volume was 1.0 ml, and all solutions were in phosphate buffer (0.1 M Na2SO4, 20 mM
NaPi, pH 6.9).
NMR Spectroscopy
1H NMR spectra were recorded
at 400 and 600 MHz on Varian-Unity 400 and Bruker DMX-600
spectrometers, respectively. Proteins were at a concentration of 28 mg/ml. Measurements were performed in phosphate buffer (0.1 M Na2SO4, 20 mM
NaPi, 99.9% D2O), and, depending on the
protein sample, the pH was varied from 6.9 to 7.5 to optimize
solubility. All two-dimensional spectra were acquired with 512 t1 increments over 2048 t2 points using the time-proportional phase
incrementation method to obtain pure-phase spectra (46) with 32 or 64 scans/t1 increment. Clean-TOCSY spectra (47)
using a MLEV-17 spin lock (48) were acquired with various mixing times in the range from 30 to 66 ms. The NOESY spectrum (49) of the ALDKG
mutant had a mixing time of 120 ms. For spectra acquired in
D2O, the residual solvent resonance was removed by
presaturation for 1.5 s with a low powered, continuous pulse using
the transmitter. For the two-dimensional experiments in
H2O, solvent suppression was accomplished by application of
the WATERGATE scheme (50) for the read pulse. In this scheme, solvent
suppression is achieved by a combination of gradient-tailored
excitation and pulsed-field gradients. Spectra were processed with
either Varian or Bruker software or, in the main, with FELIX 95.0 software (Biosym). For processing, the data were zero filled to a
matrix size of 2048 × 2048 data points prior to multiplication in
both dimensions with shifted sine-bell or Gaussian window functions,
followed by Fourier transformation. For spectra acquired at 25 °C,
chemical shifts were referenced to the residual water resonance at 4.76 ppm. The temperature inside the probe at 25 °C and higher
temperatures was calibrated with ethylene glycol.
Tryptophan Fluorescence
Samples containing reconstituted
A-crystallin were diluted with phosphate buffer (0.1 M
Na2SO4, 20 mM NaPi, pH
6.9) to a final concentration of 200 µg/ml and centrifuged for 15 min
at 15,000 × g to remove possible light scattering
particles. Fluorescence spectra were measured at 25 °C on a Hitachi
F-3000 spectrofluorometer equipped with a four-cuvette holder accessory
and a thermostated circulating water bath. The excitation wavelength
was set to 295 nm with a 5-nm band pass. Fluorescence emission was
detected over a range of 300-420 nm with a 3-nm band pass at right
angles to the incident beam after passing through a 10-mm quartz
cuvette.
Heat Stability Assay
Samples containing reconstituted
A-crystallin were diluted with phosphate buffer (0.1 M
Na2SO4, 20 mM NaPi, pH
6.9) to a final concentration of 100 µg/ml. Scattering at 360 nm was
measured as a function of temperature using a Perkin-Elmer Lambda 2 UV-visible spectrophotometer equipped with a thermostated circulation
water bath and a thermocouple to register the sample temperature.
Circular Dichroism Spectroscopy
Circular dichroism (CD)
spectra were obtained on a Jasco 720 CD spectropolarimeter. Solutions
of A-crystallin at concentrations of 0.25-0.30 mg/ml were prepared
in phosphate buffer (0.1 M Na2SO4, 20 mM NaPi, pH 6.9). Experiments were performed
over a temperature range from 21 °C to 70 °C using a quartz cell
of path length 1 mm. Samples were heated at a rate of 1 °C/min and
were left to equilibrate for an empirically determined period of
220 s at each temperature prior to accumulation of data. Spectra
acquired at a particular temperature represent an average of four
scans.
Miscellaneous Methods
Gel permeation analysis was performed
on a Superose 6 HR 10/30 prepacked column as described before (44).
High molecular mass standards (Pharmacia Biotech Inc.) were used for
calibration. Protein concentrations were determined in triplicate using
the Bradford method (51). Binding studies with the hydrophobic probe 8-anilino-1-naphthalenesulfonic acid were performed as described before
(52).
RESULTS
Purification and Gel Permeation Analysis
To explore the
influence of the C-terminal extension of bovine A-crystallin on
chaperone-like activity, we have characterized the structural and
functional properties of a number of mutants, which were originally
designed to assess the substrate requirements for transglutaminases
(53). As shown in Table I, these mutants contain
modified C termini in which charged and hydrophobic residues are
introduced. Wild-type and mutants were induced in B BL21(DE3)pLysS host
cells. Except for the ALWKG mutant, all proteins were predominantly present in the water-soluble fraction of the bacterial lysates. Apparently, the presence of a hydrophobic tryptophan residue in the
C-terminal region is unfavorable for the solubility of A-crystallin in the E. coli host cell. The expression products were
purified by native and denaturing anion exchange chromatography,
resulting in 95-98% pure proteins as estimated by SDS-PAGE (Fig.
1). Additionally, their identity was confirmed by amino
acid analysis (data not shown). To avoid isolation and purification
artifacts during further analysis, all purified proteins were
simultaneously subjected to reconstitution. The refolded proteins were
examined for their ability to form multimeric complexes on a Superose 6 gel permeation column. Table I shows that most of the altered C termini
do not affect multimerization significantly. The only exception was the ALWKG mutant, where a slightly smaller multimeric mass was
observed.
Fig. 1.
SDS-PAGE of wild-type and mutant
A-crystallins. Coomassie Brilliant Blue-stained SDS gel shows
the high levels of protein purity (3 µg of protein/lane). Molecular
mass markers (M in kDa) are indicated. Samples are as
follows: APSS (wild-type) (lane 1), APSK (lane
2), ALGKG (lane 3), ALRKG (lane 4), ALDKG (lane 5), and ALWKG (lane 6).
[View Larger Version of this Image (56K GIF file)]
Chaperone-like Activity
The chaperone-like activity of
wild-type and mutants was assessed by determining their ability to
prevent the chemically induced aggregation of insulin B-chains at
40 °C. Reduction of the disulfide bonds between the A- and B-chains
of insulin with dithiothreitol, rapidly leads to a specific
precipitation of aggregated B-chains. As shown in Fig.
2, this event can easily be monitored by measuring the
absorbance at 360 nm. Insulin was reduced at different A-crystallin to insulin mass ratios (indicated as percentages). Fig. 2A
shows that aggregation of insulin B chains is almost completely
prevented in the presence of 100% of wild-type A-crystallin. The
APSK, ALGKG, and ALRKG mutants display a small decrease of functional activity (Fig. 2, compare panels B-D with panel
A). This decrease is probably caused by the positively charged
lysine and arginine residues rather than the uncharged leucine and
glycine residues, because there is no substantial difference in
activity between the ALGKG and the APSK mutant (Fig. 2, compare
panel C with panel B). The ALDKG mutant has the
same net charge as the wild-type protein, but the polarity of its
extension is obviously increased. However, this has no detectable
effect on the ability to bind denaturing substrates (Fig. 2, compare
panel E with panel A). On the contrary, a
dramatic effect on chaperone-like activity is observed upon introducing
a hydrophobic tryptophan residue. As Fig. 2F shows, a
considerable level of insulin B aggregation occurs even at an ALWKG
mutant to insulin mass ratio of 100%, whereas the wild-type and the
other mutants provide almost complete protection at this ratio (Fig. 2,
A-E). Thus, unlike charged residues, a strongly hydrophobic
residue in the C-terminal extension can seriously disturb functional
activity.
Fig. 2.
Chaperone-like activity of wild-type and
mutant A-crystallins. Reduction-induced aggregation of insulin
B is given as a function of time in the absence and presence of various
amounts of wild-type (A) and mutant (B-F)
A-crystallins. Mutants are designated by their C-terminal sequences.
The A to insulin mass ratios in the various experiments are
indicated as percentages. Proteins were in a total volume of 1.0 ml
phosphate buffer, pH 6.9, and the incubation temperature was 40 °C.
The insulin concentration was 245 µg/ml, and the reduction was
initiated by addition of 20 µl of 1 M dithiothreitol. All
protein concentrations were determined in triplicate using the Bradford
assay.
[View Larger Version of this Image (27K GIF file)]
NMR Spectroscopy
The ALDKG and ALWKG mutants were subjected
to two-dimensional 1H NMR spectroscopy to determine whether
the diminished functional activity of the latter is related to an
altered conformation of the C-terminal extension. Fig. 3
shows the cross-peaks arising from -CH resonances in TOCSY spectra
at 25 °C of the ALDKG and ALWKG mutants in D2O. The
majority of the cross-peaks in the ALDKG spectrum (Fig. 3A)
were assigned using the sequential-assignment procedure of Wuthrich
(54), which involved the combined use of TOCSY and NOESY spectra in
H2O (data not shown). The chemical shifts of the assigned
resonances in the ALDKG spectra (TOCSY and NOESY) are very similar to
those it shares with wild-type A-crystallin (35) and random coil
peptides (55). Therefore, it is clear that this mutant has a flexible
C-terminal extension consisting of the last 10 residues (from Glu-165
to Gly-174) and that this extension has little preferred conformation.
Comparison of panels A and B (Fig. 3) shows that
the ALWKG mutant displays fewer cross-peaks than the ALDKG mutant. For
the ALWKG mutant, cross-peaks from the -CH protons were present for
the first part of the C-terminal extension (Glu-165 to Ala-170) but not
for the remainder (Leu-171 to Lys-173). In the ALDKG mutant, Gly-174
-CH2 does not give rise to cross-peaks in this region of
the TOCSY spectrum as these protons are equivalent. It was apparent
from the one-dimensional 1H spectra of both mutants,
however, that the strong singlet resonance from the -CH2
protons of Gly-174 in the ALDKG mutant (at 3.73 ppm) was absent in the
ALWKG mutant (data not shown). No cross-peaks were observed from
Lys-166 -CH in the TOCSY spectra of the ALWKG mutant, whereas weak
signals were observed in the spectra of wild-type A-crystallin (35)
and the ALDKG mutant. This absence could be explained by additional
weakness arising from a reduced flexibility due to Lys-166 being at the
start of the C-terminal extension and/or the proximity of the Lys-166
-CH resonance to the water resonance resulting in cross-saturation
effects. Despite the absence of cross-peaks from the -CH protons of
residues in the terminal part of the extension in the ALWKG mutant,
resonances were observed from their side chains, e.g. weak
cross-peaks were present in the TOCSY spectra between the , -CH
and -CH3 protons of Leu-171 and from the - to
-CH2 protons of Lys-173 and Lys-166. In the one-dimensional 1H NMR spectrum of the ALWKG mutant, broad
resonances were also observed at chemical shifts indicative of a
tryptophan residue. Presumably, these resonances arise from the
solvent-accessible aromatic protons of Trp-172. In the TOCSY spectrum,
however, these resonances did not give rise to any cross-peaks, which
implies that they have reduced flexibility. In conclusion, the NMR data indicate that the terminal sequence of the C-terminal extension in the
ALWKG mutant (Leu-171 to Gly-174) has reduced flexibility compared with
the first part of the extension (Glu-165 to Ala-170) and compared with
the entire C-terminal extension in the ALDKG mutant.
Fig. 3.
1H NMR spectroscopy of the ALDKG
and ALWKG mutants. TOCSY spectra were recorded at 400 MHz and
25 °C. Shown are the -CH resonances of the ALDKG mutant in
phosphate buffer in D2O, pH 6.9 (A), and the
ALWKG mutant in phosphate buffer in D2O, pH 7.5 (B). Cross-peak assignments based on NOESY sequential
analysis are indicated.
[View Larger Version of this Image (24K GIF file)]
Tryptophan Fluorescence Spectroscopy
The ALWKG mutant was
subjected to fluorescence spectroscopy to probe the polarity of the
micro-environment in which the introduced tryptophan is located. In
general, the fluorescence emission maximum of tryptophan residues can
vary from about 330 nm (completely buried) to 350 nm (completely
exposed) (56). The ALWKG mutant has two tryptophan residues, one at
position 9 and the other at position 172 in the C-terminal extension.
Both residues contribute to the measured emission spectrum shown in
Fig. 4. Since the ALDKG and ALWKG mutants share the
Trp-9 in the N-terminal domain, the contribution of the additional
Trp-172 in the latter could be determined by calculating the difference
between the measured emission spectra. As shown in Fig. 4, the
extrapolated spectrum of Trp-172 has a max of 348 nm,
indicating that this residue is almost fully exposed to the solvent.
Furthermore, the emission intensity of Trp-172 is much lower than that
of Trp-9, which also indicates a polar environment because exposed
residues display a relatively low quantum yield.
Fig. 4.
Tryptophan fluorescence spectroscopy of the
ALDKG and ALWKG mutants. Proteins were in a total volume of 1.5 ml
of phosphate buffer, pH 6.9, and their concentration of 200 µg/ml was
precisely calibrated using the Bradford assay. The excitation
wavelength was 295 nm, and the emission spectra were recorded in
duplicate using two independent sample preparations. The difference
spectrum ( ) was calculated by subtracting the ALDKG spectrum from
the ALWKG spectrum. The ALDKG spectrum was identical to the APSS
wild-type spectrum (data not shown).
[View Larger Version of this Image (20K GIF file)]
Thermostability
To determine whether the thermostability of
A-crystallin is conserved upon C-terminal alterations, wild-type and
mutants were heated and the absorption at 360 nm was monitored as a
function of temperature. As shown in Fig. 5A,
the ALWKG mutant, but not the wild-type and the other mutants, rapidly
starts to precipitate at 59 °C. To probe further the reduced
temperature stability of the ALWKG mutant, the conformation of the
ALWKG and ALDKG mutants was investigated as a function of temperature
using CD and NMR spectroscopy. Both mutants gave at room temperature a
CD spectrum that is typical for -crystallin, i.e. the
profiles were characteristic for a high proportion of -sheet
structure, showing an ellipticity minimum at 218 nm (data not shown).
With increasing temperatures above 44 °C, an increase in ellipticity
at 205 nm was observed for the ALDKG mutant, such that when the
ellipticity was plotted against temperature, a sigmoidal-shaped curve
was obtained with a half-point at around 50 °C (Fig. 5B).
The increase in ellipticity at 205 nm is indicative of an increase in
random coil structure of the protein at these higher temperatures.
Similar behavior was observed for native -crystallin, except that
the midpoint of this transition was at around 60 °C (57). The CD
spectra of the ALWKG mutant were similar to those for the ALDKG mutant over a range from 20 °C to 52 °C (data not shown). However,
between 52 °C and 55 °C, the ALWKG mutant precipitated, which was
reflected in the uncharacteristic change of ellipticity at 205 nm (Fig. 5B). Nevertheless, the similarities between the CD spectra
for both mutants below 52 °C suggest that the ALWKG mutant does not undergo any gross unfolding or unusual conformational changes prior to
precipitation.
Fig. 5.
Thermostability of wild-type and mutant
A-crystallins. A, aggregation of wild-type and mutant
A-crystallins as a function of temperature. Proteins were in a total
volume of 1.0 ml of phosphate buffer, pH 6.9, and their concentration
was 100 µg/ml. The behavior of APSS wild-type and the APSK, ALGKG,
and ALRKG mutants was identical to that of the ALDKG mutant (data not
shown). B, temperature dependence of ellipticity at 205 nm in CD spectra of the ALDKG and ALWKG mutants. Proteins were in phosphate buffer, pH 6.9, and their concentration was 250-300 µg/ml.
Far-UV circular dichroism spectra of the ALDKG and ALWKG mutants were
recorded at various temperatures (data not shown), and from the average
of four scans the ellipticity at 205 nm was determined.
[View Larger Version of this Image (17K GIF file)]
Temperature-dependent NMR analysis of the ALWKG mutant was
consistent with this result. One-dimensional 1H NMR spectra
were acquired in 5 °C increments from 25 °C to 55 °C with
TOCSY spectra being acquired at 35, 45, and 55 °C. Compared with the
spectrum at 25 °C (Fig. 3), there was little change in the NMR
spectrum with increasing temperature up to 50 °C. Thus, the same
cross-peaks were present and no new cross-peaks were observed,
indicating that there was no major unfolding or change in flexibility
of the protein at higher temperature. At 55 °C, however, the
spectrum became broad and sensitivity was lost due to the sample
precipitating out of solution. It would seem, therefore, that
increasing temperature up to approximately 55 °C had little effect
on the flexibility of the C-terminal extension of the ALWKG mutant or
other regions in the molecule.
DISCUSSION
Since it became clear a few years ago that -crystallin is a
small heat shock protein with a role in various non-lenticular tissues,
there has been great interest in determining the mechanism by which
-crystallin interacts in vitro with aggregation-prone proteins. Up to now, it is not known which domains or structural elements of -crystallin subunits are involved in this interaction. In this paper we have focused on structural and functional effects of
amino acid replacements in the C-terminal extension of bovine A-crystallin. As shown in Fig. 2, chaperone-like activity is only
slightly influenced upon introduction of additional charged residues in
this region. In contrast, Fig. 2F demonstrates that insertion of a hydrophobic tryptophan residue decreases the
aggregation-suppressing behavior dramatically. To understand this
functional behavior at a structural level, the ALWKG mutant was
subjected to biophysical examination to explore the structural aspects
of its extension. Two-dimensional 1H NMR analysis of the
ALDKG and ALWKG mutants showed that substitution of a hydrophilic
aspartic acid residue by a hydrophobic tryptophan residue at position
172 leads to a pronounced reduction in flexibility specifically in the
vicinity of this residue (Fig. 3). The introduction of tryptophan at
position 172 makes the terminal region of the extension relatively
hydrophobic in character, i.e. the apolar amino acids
Ala-170, Leu-171, Trp-172, and Gly-174 are only offset by the charged
Lys-173. Considering this in light of the fact that -crystallin is
known to expose a significant hydrophobic surface to solution (37, 39),
the reduced flexibility of Ala-170 to Gly-174 is likely to be the
result of an extension-domain interaction. This interaction might
explain why the multimeric mass of the ALWKG mutant appears to be
somewhat lower than that of the wild-type and the other mutants (Table
I), i.e. immobilization of the C-terminal extension slightly
diminishes the average Stokes' radius of the multimeric particles.
Furthermore, the observation that the immobilized tryptophan is still
solvent-accessible (Fig. 4) indicates that its binding site is not
buried in a domain structure. This result supports the possibility that
the hydrophobic extension interacts with substrate binding sites, as
these sites are probably located on the surface of the multimeric
particles to allow for an efficient aspecific interaction with
unfolding proteins.
The immobilization of the terminal part of the ALWKG extension could
explain the decreased chaperone-like activity of the mutant in several
ways. First of all, as mentioned above it might be possible that
binding of the extension reduces the amount of hydrophobic surface
available for unfolding substrates. However, this concept is apparently
not supported by binding studies with the fluorescent probe
8-anilino-1-naphthalenesulfonic acid, because at 40 °C no
significant differences in absolute hydrophobicity were found between
wild-type, the ALDKG mutant, and the ALWKG mutant (data not shown).
Another possibility is that the immobilized extension diminishes the
accessibility of the substrate binding sites by steric hindrance. On
the basis of the present data, this hypothesis cannot be excluded,
although it does not provide a rationale as to why -crystallin
subunits need a flexible C-terminal extension at all. Sequence
comparisons show that the extension is quite variable, but so far no
mammalian -crystallin subunits have been found lacking such an
extension (12, 58). -Crystallin multimers seem to have a defined
number of substrate binding sites, which may become occupied by
denaturing proteins until a level of saturation is reached (44, 59).
This occupation is accompanied by an increase of hydrophobicity because
the substrate proteins are bound in a state that is at least partially
unfolded (60). Considering this increasing hydrophobicity together with
the observation that the extension of wild-type A-crystallin is not
affected by substrate binding (60), it might be possible that the
extension functions as a sort of solubilizer in the complex. That is to say, the strong hydration of the polar extensions compensates for the
relatively high surface hydrophobicity of the complexes formed between
A-crystallin and unfolded substrates. Consequently, the poor
functional activity of the ALWKG mutant can be explained by the
comparatively high tendency of ALWKG-substrate complexes to aggregate
because their extensions are immobilized and far less hydrated than
those in wild-type A-crystallin and the ALDKG mutant.
The heat-induced precipitation of the ALWKG mutant (Fig. 5A)
is a remarkable observation because the wild-type and the other mutants
are very thermosoluble. In addition, native -crystallin and mutants
of A-crystallin that were analyzed previously, including the
elongated Ains-polypeptide, do not precipitate up to at
least 75 °C (30, 44, 52). The CD and NMR experiments do not provide
any evidence that precipitation of ALWKG mutant at around 55 °C is
preceded by precocious unfolding of domain structures. Therefore, this insolubilization probably has a more indirect cause. Although -crystallin does not denature upon heating, at least some of the
-sheet structure is irreversibly lost in the temperature range
between approximately 50 °C and 70 °C (57). In addition, differential scanning calorimetry has revealed a broad endothermic transition for -crystallin at about 60 °C (57, 61).
Interestingly, hydrophobic probe binding studies suggest that the
apparent thermotropic transition of -crystallin is accompanied by a
significant increase in surface hydrophobicity (37, 39). In general,
proteins become more hydrophobic with increasing temperature because
the water ordering around their apolar surfaces tends to melt out (56). Although this thermodynamic phenomenon may play a role to some extent,
it does not explain why the surface hydrophobicity of -crystallin is
still increased after a cooling down period (39). Therefore, it is
conceivable that the increased surface hydrophobicity is directly
correlated to an irreversible structural transition. Fig. 5B
shows that the ALDKG and ALWKG mutants display a loss of -sheet
structure with increasing temperature similar to that for native
-crystallin. Furthermore, the precipitation of the ALWKG mutant
occurs between 52 and 59 °C, which is in the same range as the
thermotropic transition temperature of -crystallin. Because of this,
precipitation of the ALWKG mutant may also be related to a structural
transition and a concomitant increase in surface hydrophobicity.
Basically then, the temperature-induced insolubilization of the ALWKG
mutant may have the same cause as its diminished chaperone-like
activity, namely that the solubilizing capacity of the immobilized
extensions is insufficient to compensate for the increasing
hydrophobicity of the domain core of the protein.
Whereas introduction of a tryptophan causes structural changes,
i.e. immobilization of the C-terminal extension and a
concomitant functional deterioration, insertion of additional charged
residues in the C-terminal extension of A-crystallin has only minor
effects on the protein's functionality. Perhaps the very presence of a hydrated and flexible extension is more important for solubility and
chaperone-like activity than its precise amino acid sequence. The
importance of the extension has been noticed before because the
C-terminal domain of rat A-crystallin becomes completely insoluble
upon removal of the 23 C-terminal
residues.2 Furthermore, the observation
that the ALWKG mutant is soluble under normal conditions may well be
due to the fact that part of its extension, i.e. Glu-165 to
Ala-170, is still flexible.
We did not study the effect of hydrophobic residues other than
tryptophan. However, it is conceivable that any hydrophobic stretch
which restricts the conformational freedom of the C-terminal extension
will also affect functional activity. This implies that the polar
extension of wild-type A-crystallin has an important physiological
function. In fact, the evolutionary conservation of such a polar
extension may be dictated by the fact that a non-hydrophobic unstructured C-terminal region is required for increasing the capacity
of A-crystallin to form soluble complexes with aggregation-prone polypeptides.
FOOTNOTES
*
This work was supported by the Netherlands Organization for
Scientific Research (NWO), National Institutes of Health Grant EY09683
(to W. W. de J.), and the National Health and Medical Research Council
of Australia. The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: Dept. of
Biochemistry, University of Nijmegen, P. O. Box 9101, NL-6500 HB
Nijmegen, The Netherlands. Tel.: 31-24-3616848/3614254; Fax:
31-24-3540525; E-mail: w.dejong{at}bioch.kun.nl.
1
The abbreviations used are: hsp, heat shock
protein(s); TOCSY, total correlation spectroscopy; NOESY, nuclear
Overhauser effect spectroscopy; PAGE, polyacrylamide gel
electrophoresis.
2
P. R. L. A. van den IJssel and W. W. de Jong,
unpublished results.
Acknowledgments
We thank Lennard Horstink and Dr. William
Price for useful discussions.
REFERENCES
-
Groenen, P. J., Merck, K. B., de Jong, W. W., and Bloemendal, H.
(1994)
Eur. J. Biochem.
225,
1-19
[Medline]
[Order article via Infotrieve]
-
Kato, K., Shinohara, H., Kurobe, N., Goto, S., Inaguma, Y., and Ohshima, K.
(1991)
Biochim. Biophys. Acta
1080,
173-180
[CrossRef][Medline]
[Order article via Infotrieve]
-
Srinivasan, A. N., Nagineni, C. N., and Bhat, S. P.
(1992)
J. Biol. Chem.
267,
23337-23341
[Abstract/Free Full Text]
-
Deretic, D., Aebersold, R. H., Morrison, H. D., and Papermaster, D. S.
(1994)
J. Biol. Chem.
269,
16853-16861
[Abstract/Free Full Text]
-
Bhat, S. P., and Nagineni, C. N.
(1989)
Biochem. Biophys. Res. Commun.
158,
319-325
[CrossRef][Medline]
[Order article via Infotrieve]
-
van Noort, J. M., van Sechel, A. C., Bajramovic, J. J., Elouagmiri, M., Polman, C. H., Lassmann, H., and Ravid, R.
(1995)
Nature
375,
798-801
[CrossRef][Medline]
[Order article via Infotrieve]
-
Iwaki, T., Kume Iwaki, A., Liem, R. K., and Goldman, J. E.
(1989)
Cell
57,
71-78
[CrossRef][Medline]
[Order article via Infotrieve]
-
Iwaki, T., Iwaki, A., Tateishi, J., Sakaki, Y., and Goldman, J. E.
(1993)
Am. J. Pathol.
143,
487-495
[Abstract]
-
Lowe, J., McDermott, H., Pike, I., Spendlove, I., Landon, M., and Mayer, R. J.
(1992)
J. Pathol.
166,
61-68
[CrossRef][Medline]
[Order article via Infotrieve]
-
Renkawek, K., Voorter, C. E., Bosman, G. J., van Workum, F. P., and de Jong, W. W.
(1994)
Acta Neuropathol. Berl.
87,
155-160
[Medline]
[Order article via Infotrieve]
-
Ingolia, T. D., and Craig, E. A.
(1982)
Proc. Natl. Acad. Sci. U. S. A.
79,
2360-2364
[Abstract/Free Full Text]
-
Caspers, G-J., Leunissen, J. A. M., and de Jong, W. W.
(1995)
J. Mol. Evol.
40,
238-248
[CrossRef][Medline]
[Order article via Infotrieve]
-
Klemenz, R., Frohli, E., Steiger, R. H., Schafer, R., and Aoyama, A.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
3652-3656
[Abstract/Free Full Text]
-
van den IJssel, P. R., Overkamp, P., Knauf, U., Gaestel, M., and de Jong, W. W.
(1994)
FEBS Lett.
355,
54-56
[CrossRef][Medline]
[Order article via Infotrieve]
-
Chiesi, M., Longoni, S., and Limbruno, U.
(1990)
Mol. Cell Biochem.
97,
129-136
[Medline]
[Order article via Infotrieve]
-
Miron, T., Vancompernolle, K., Vandekerckhove, J., Wilchek, M., and Geiger, B.
(1991)
J. Cell. Biol.
114,
255-261
[Abstract/Free Full Text]
-
Voorter, C. E., Mulders, J. W., Bloemendal, H., and de Jong, W. W.
(1986)
Eur. J. Biochem.
160,
203-210
[Medline]
[Order article via Infotrieve]
-
Stokoe, D., Engel, K., Campbell, D. G., Cohen, P., and Gaestel, M.
(1992)
FEBS Lett.
313,
307-313
[CrossRef][Medline]
[Order article via Infotrieve]
-
Voorter, C. E., Wintjes, L., Bloemendal, H., and de Jong, W. W.
(1992)
FEBS Lett.
309,
111-114
[CrossRef][Medline]
[Order article via Infotrieve]
-
Arrigo, A.-P., Suhan, J. P., and Welch, W. J.
(1988)
Mol. Cell. Biol.
8,
5059-5071
[Abstract/Free Full Text]
-
Horwitz, J.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
10449-10453
[Abstract/Free Full Text]
-
Jakob, U., Gaestel, M., Engel, K., and Buchner, J.
(1993)
J. Biol. Chem.
268,
1517-1520
[Abstract/Free Full Text]
-
Merck, K. B., Groenen, P. J. T. A., Voorter, C. E. M., de Haard-Hoekman, W. A., Horwitz, J., Bloemendal, H., and de Jong, W. W.
(1993)
J. Biol. Chem.
268,
1046-1052
[Abstract/Free Full Text]
-
Carver, J. A., Aquilina, J. A., and Truscott, R. J. W.
(1994)
Exp. Eye Res.
59,
231-234
[CrossRef][Medline]
[Order article via Infotrieve]
-
Singh, K., Groth-Vasselli, B., Kumosinski, T. F., and Farnsworth, P. N.
(1995)
FEBS Lett.
372,
283-287
[CrossRef][Medline]
[Order article via Infotrieve]
-
Bindels, J. G., Siezen, R. J., and Hoenders, H. J.
(1979)
Ophthalmic Res.
11,
711-724
-
Tardieu, A., Laporte, D., Licinio, P., Krop, B., and Delaye, M.
(1986)
J. Mol. Biol.
192,
711-724
[CrossRef][Medline]
[Order article via Infotrieve]
-
Wistow, G.
(1993)
Exp. Eye Res.
56,
729-732
[CrossRef][Medline]
[Order article via Infotrieve]
-
Siezen, R. J., and Argos, P.
(1983)
Biochim. Biophys. Acta
748,
56-67
[CrossRef][Medline]
[Order article via Infotrieve]
-
Maiti, M., Kono, M., and Chakrabarti, B.
(1988)
FEBS Lett.
236,
109-114
[CrossRef][Medline]
[Order article via Infotrieve]
-
Wistow, G.
(1985)
FEBS Lett.
181,
1-6
[CrossRef][Medline]
[Order article via Infotrieve]
-
van den Oetelaar, P. J., and Hoenders, H. J.
(1989)
Biochim. Biophys. Acta
995,
91-96
[CrossRef][Medline]
[Order article via Infotrieve]
-
Merck, K. B., de Haard-Hoekman, W. A., Oude Essink, B. B., Bloemendal, H., and de Jong, W. W.
(1992)
Biochim. Biophys. Acta
1130,
267-276
[Medline]
[Order article via Infotrieve]
-
Carver, J. A., Aquilina, J. A., and Truscott, R. J.
(1993)
Biochim. Biophys. Acta
1164,
22-28
[CrossRef][Medline]
[Order article via Infotrieve]
-
Carver, J. A., Aquilina, J. A., Truscott, R. J., and Ralston, G. B.
(1992)
FEBS Lett.
311,
143-149
[CrossRef][Medline]
[Order article via Infotrieve]
-
Carver, J. A., Esposito, G., Schwedersky, G., and Gaestel, M.
(1995)
FEBS Lett.
369,
305-310
[CrossRef][Medline]
[Order article via Infotrieve]
-
Raman, B., and Rao, Ch. M.
(1994)
J. Biol. Chem.
269,
27264-27268
[Abstract/Free Full Text]
-
Raman, B., Ramakrishna, T., and Rao, C. M.
(1995)
FEBS Lett.
365,
133-136
[CrossRef][Medline]
[Order article via Infotrieve]
-
Das, K. P., and Surewicz, W. K.
(1995)
FEBS Lett.
369,
321-325
[CrossRef][Medline]
[Order article via Infotrieve]
-
Kelley, M. J., David, L. L., Iwasaki, N., Wright, J., and Shearer, T. R.
(1993)
J. Biol. Chem.
268,
18844-18849
[Abstract/Free Full Text]
-
Takemoto, L.
(1992)
Exp. Eye Res.
59,
239-242
-
de Jong, W. W., Lubsen, N. H., and Kraft, H. J.
(1994)
Prog. Retinal Eye Res.
13,
391-442
[CrossRef]
-
Studier, F. W., Rosenberg, A. H., Dunn, J. J., and Dubendorff, J. W.
(1989)
Methods Enzymol.
185,
60-89
-
Smulders, R. H. P. H., van Geel, I. G., Gerards, W. L. H., Bloemendal, H., and de Jong, W. W.
(1995)
J. Biol. Chem.
270,
13916-13924
[Abstract/Free Full Text]
-
Farahbakhsh, Z. T., Huang, Q. L., Ding, L. L., Altenbach, C., Steinhoff, H. J., Horwitz, J., and Hubbell, W. L.
(1995)
Biochemistry
34,
509-516
[CrossRef][Medline]
[Order article via Infotrieve]
-
Marion, D., and Wuthrich, K.
(1983)
Biochem. Biophys. Res. Commun.
113,
967-974
[CrossRef][Medline]
[Order article via Infotrieve]
-
Griesinger, C., Otting, G., Wuthrich, K., and Ernst, R. R.
(1988)
J. Am. Chem. Soc.
110,
7870-7872
[CrossRef]
-
Bax, A., and Davis, D. G.
(1985)
J. Magn. Reson.
65,
355-360
-
Jeener, J., Meier, B. H., Bachmann, P., and Ernst, R. R.
(1979)
J. Chem. Phys.
48,
286-292
-
Piotto, M., Saudek, V., and Sklenar, V.
(1992)
J. Biomol. NMR
2,
661-665
[CrossRef][Medline]
[Order article via Infotrieve]
-
Bradford, M. M.
(1976)
Anal. Biochem.
72,
248-254
[CrossRef][Medline]
[Order article via Infotrieve]
-
Smulders, R. H. P. H., Merck, K. B., Aendekerk, J., Horwitz, J., Takemoto, L., Slingsby, C., Bloemendal, H., and de Jong, W. W.
(1995)
Eur. J. Biochem.
232,
834-838
[Medline]
[Order article via Infotrieve]
-
Grootjans, J. J., Groenen, P. J. T. A., and de Jong, W. W.
(1995)
J. Biol. Chem.
270,
22855-22858
[Abstract/Free Full Text]
-
Wuthrich, K.
(1986)
NMR of Proteins and Nucleic Acids, John Wiley & Sons, New York
-
Lebreton, E. R., and Carver, J. A.
(1996)
Int. J. Pept. Protein Res.
47,
9-19
[Medline]
[Order article via Infotrieve]
-
Creighton, T. E.
(1993)
Proteins: Structures and Molecular Properties, p. 270, W. H. Freeman, New York
-
Surewicz, W. K., and Olesen, P. R.
(1995)
Biochemistry
34,
9655-9660
[CrossRef][Medline]
[Order article via Infotrieve]
-
Hendriks, W., Sanders, J., de Leij, L., Ramaekers, F., Bloemendal, H., and de Jong, W. W.
(1988)
Eur. J. Biochem.
174,
133-137
[Medline]
[Order article via Infotrieve]
-
Wang, K., and Spector, A.
(1994)
J. Biol. Chem.
269,
13601-13608
[Abstract/Free Full Text]
-
Carver, J. A., Guerreiro, N., Nicholls, K. A., and Truscott, R. J. W.
(1995)
Biochim. Biophys. Acta
1252,
251-260
[CrossRef][Medline]
[Order article via Infotrieve]
-
Walsh, M. T., Sen, A. C., and Chakrabarti, B.
(1991)
J. Biol. Chem.
266,
20079-20084
[Abstract/Free Full Text]
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Biswas, S. Lewis, B. Wang, M. Miyagi, P. Santoshkumar, M. H. Gangadhariah, and R. H. Nagaraj
Chemical Modulation of the Chaperone Function of Human {alpha}A-Crystallin
J. Biochem.,
July 1, 2008;
144(1):
21 - 32.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Saha, A. Sharma, A. Dhar, B. Bhattacharyya, S. Roy, and S. K. Das Gupta
Antagonists of Hsp16.3, a Low-Molecular-Weight Mycobacterial Chaperone and Virulence Factor, Derived from Phage-Displayed Peptide Libraries
Appl. Envir. Microbiol.,
November 1, 2005;
71(11):
7334 - 7344.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Bhattacharyya, S. Ray, S. Bhattacharya, and A. Chakrabarti
Chaperone Activity and Prodan Binding at the Self-associating Domain of Erythroid Spectrin
J. Biol. Chem.,
December 31, 2004;
279(53):
55080 - 55088.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Gupta and O. P. Srivastava
Deamidation Affects Structural and Functional Properties of Human {alpha}A-Crystallin and Its Oligomerization with {alpha}B-Crystallin
J. Biol. Chem.,
October 22, 2004;
279(43):
44258 - 44269.
[Abstract]
[Full Text]
[PDF]
|
 |
| |